![hex](https://www.ppd.com/wp-content/uploads/2019/11/hex_2-1150x600.png)
Nitrosamines Analysis Case Study
![](https://www.ppd.com/wp-content/uploads/2021/04/GMP-Nitrosamines-Case-Study-Thumb.jpg)
N-nitrosamines are probable human carcinogens which must be measured and determined to not exceed very low levels. Starting in 2018 after a series of events, a greater regulatory focus was put on N-nitrosamine contamination. In this case study, PPD® Laboratories GMP lab shares insight on how they completed method development, validation and testing to screen and quantitate NDMA in a drug product for a large pharmaceutical customer.